ADVANCED MALIGNANCIES
Clinical trials for ADVANCED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug Follow-Up study seeks Long-Term safety answers
Disease control OngoingThis study looks at the long-term safety and effects of certain cancer drugs in people with advanced tumors. Participants must have already been in a related earlier study and still benefit from the treatment. The goal is to track side effects and see how well the drugs work over…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 17, 2026 08:02 UTC
-
New hope for advanced lung cancer: immune-boosting drug shows promise in early trial
Disease control OngoingThis early-stage study tests a drug called cemiplimab, alone or with other medicines, in Japanese patients with advanced lung cancer. The goal is to see if it is safe and can help shrink tumors by boosting the immune system. About 146 people will take part, and the study focuses …
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New cancer drug AB598 enters early human safety testing
Disease control OngoingThis early-phase study tests the safety of a new drug called AB598, given alone or with other treatments, in about 40 people with advanced solid tumors (e.g., lung, bladder, breast, or ovarian cancer). The main goal is to see if the drug is safe and tolerable. Participants must h…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Cancer patients get continued access to promising drug in Follow-Up study
Disease control OngoingThis study offers continued treatment with avelumab to cancer patients who are already benefiting from it in earlier Pfizer studies. It includes safety monitoring and survival follow-up for people with advanced cancers like lung, ovarian, and bladder cancer. The goal is to keep p…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New drug shows promise in shrinking advanced tumors
Disease control OngoingThis study tests an experimental drug called PF-06801591 that helps the immune system fight cancer. It is for people with advanced solid tumors or non-small-cell lung cancer that has not responded to other treatments. The goal is to see if the drug is safe and can control the can…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 05, 2026 11:53 UTC